2Green JR, Muller K, Jageggi KA Preclinical Pharmacology of CGP42446. a new: Potent, heterocyclic bispbosphonate compound[J]. J Bone Miner Res. 1994;9(5):745 -751.
3Coleman RE. Purohit OP. Black C, et al. I bandronate: a well toierated new oral bisphosphonate for the treatment of bone metastases[J].Breast, 1995;4(9) :236.
4Jeal W, Barradell LB, Mctavish D. Alendronste: a review of it pharmcologocal properties and therapeutic efficacy in postmentopausal osteoporosis[J]. Drugs, 1997;53(3):415.
5Biosser S, Magnette S, Frappart L, et al. Bisphosphonate inhibit prostate and breast carcinoma cell adinesion to ummineralized and mineralized bone etra cellular matrioes[J]. Cancer Res, 1997;57(18):3890.
3Kondo T, Hozumi T, Goto T, et al. Intraoperative radiotherapy combined with posterior deeompressiort and stabilization for non-ambulant paralytic patients due to spinal metastasis [J]. Spine (Phila Pa 1976) ,2008,33 (17):1898-1904.
